Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 10 results.
User Information
Export Records
  1. 1.   Antiviral activity of alpha-helical stapled peptides designed from the HIV-1 capsid dimerization domain
  2. Zhang, H. T.; Curreli, F.; Zhang, X. H.; Bhattacharya, S.; Waheed, A. A.; Cooper, A.; Cowburn, D.; Freed, E. O.; Debnath, A. K.
  3. Retrovirology. 2011, May; 8: 18.
  1. 2.   Novel approaches to inhibiting HIV-1 replication
  2. Adamson, C. S.; Freed, E. O.
  3. Antiviral Research. 2010, Jan; 85(1): 119-141.
  1. 3.   Residues in the Stalk Domain of the Hendra Virus G Glycoprotein Modulate Conformational Changes Associated with Receptor Binding
  2. Bishop, K. A.; Hickey, A. C.; Khetawat, D.; Patch, J. R.; Bossart, K. N.; Zhu, Z. Y.; Wang, L. F.; Dimitrov, D. S.; Broder, C. C.
  3. Journal of Virology. 2008 82(22): 11398-11409.
  1. 4.   Virion envelope content, infectivity, and neutralization sensitivity of simian immunodeficiency virus
  2. Yuste, E.; Johnson, W.; Pavlakis, G. N.; Desrosiers, R. C.
  3. Journal of Virology. 2005, OCT; 79(19): 12455-12463.
  1. 5.   Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5
  2. Dong, H. F.; Wigmore, K.; Carrington, M. N.; Dean, M.; Turpin, J. A.; Howard, O. M. Z.
  3. Genes and Immunity. 2005, OCT; 6(7): 609-619.
  1. 6.   Residues 207, 216, and 221 and the catalytic activity of mGSTA1-1 and mGSTA2-2 toward benzo a pyrene-(7R,8S)-diol- (9S,10R)-epoxide
  2. Gu, Y. J.; Xiao, B.; Wargo, H. L.; Bucher, M. H.; Singh, S. V.; Ji, X. H.
  3. Biochemistry. 2003 42(4): 917-921.
  1. 7.   Retroviral mutation rates and reverse transcriptase fidelity
  2. Svarovskaia, E. S.; Cheslock, S. R.; Zhang, W. H.; Hu, W. S.; Pathak, V. K.
  3. Frontiers in Bioscience. 2003 8: D117-D134.
  1. 8.   The M184V mutation reduces the selective excision of zidovudine 5 '-monophosphate (AZTMP) by the reverse transcriptase of human immunodeficiency virus type 1
  2. Boyer, P. L.; Sarafianos, S. G.; Arnold, E.; Hughes, S. H.
  3. Journal of Virology. 2002 76(7): 3248-3256.
  1. 9.   Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus
  2. Chertova, E.; Bess, J. W.; Crise, B. J.; Sowder, R. C.; Schaden, T. M.; Hilburn, J. M.; Hoxie, J. A.; Benveniste, R. E.; Lifson, J. D.; Henderson, L. E.; Arthur, L. O.
  3. Journal of Virology. 2002 76(11): 5315-5325.
  1. 10.   Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells
  2. Tang, S. X.; Murakami, T.; Agresta, B. E.; Campbell, S.; Freed, E. O.; Levin, J. G.
  3. Journal of Virology. 2001 75(19): 9357-9366.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel